HMGB1 ELISA Kit

Produktnummer ABIN414391

Human HMGB1 ELISA Kit, Colorimetric Assay für die Quantifizierung von Human HMGB1 und es wurde in 56+ Publikationen zitiert.

Kurzübersicht für HMGB1 ELISA Kit (ABIN414391)

Target: HMGB1 (High Mobility Group Box 1 (HMGB1))

Reaktivität: Human

Nachweismethode: Colorimetric

Methodentyp: Sandwich ELISA

Detektionsbereich: 62.5 pg/mL - 4000 pg/mL

Applikation: ELISA

Proben: Plasma, Serum

Produktdetails HMGB1 ELISA Kit

Untere Nachweisgrenze: 62.5 pg/mL

Verwendungszweck: The kit is a sandwich enzyme immunoassay for in vitro quantitative measurement of HMG1 in human serum, plasma.

We offer validation data (WB) for the kit components. So you can be sure to order a reliable ELISA kit product composed of high quality reagents.

Analytische Methode: Quantitative

Spezifität:

This assay has high sensitivity and excellent specificity for detection of High Mobility Group Protein 1 (HMGB1).
No significant cross-reactivity or interference between High Mobility Group Protein 1 (HMGB1) and analogues was observed.

Kreuzreaktivität (Details): No significant cross-reactivity or interference between High Mobility Group Protein 1 (HMG1) and analogues was observed.

Sensitivität: < 28.3 pg/mL

Bestandteile:

• Pre-coated, 96-well strip plate
• Plate sealer
• Standard
• Standard Diluent
• Detection Reagent A
• Assay Diluent A
• Detection Reagent B
• Assay Diluent B
• TMB Substrate
• Stop Solution
• Wash Buffer (30X)
• Instruction manual

Benötigtes Material:

• Microplate reader with 450 nm filter.
• Precision single or multi-channel pipettes and disposable tips.
• Eppendorf Tubes for diluting samples.
• Deionized or distilled water.
• Absorbent paper for blotting the microtiter plate.
• Container for Wash Solution

Anwendungsinformationen

Applikationshinweise:

• Limited by the current condition and scientific technology, we cannot completely conduct the comprehensive identification and analysis on the raw material provided by suppliers. So there might be some qualitative and technical risks to use the kit.
• The final experimental results will be closely related to validity of the products, operation skills of the end users and the experimental environments. Please make sure that sufficient samples are available.
• Kits from different batches may be a little different in detection range, sensitivity and color developing time.
• Do not mix or substitute reagents from one kit lot to another. Use only the reagents supplied by manufacturer.
• Protect all reagents from strong light during storage and incubation. All the bottle caps of reagents should be covered tightly to prevent the evaporation and contamination of microorganism.
• There may be some foggy substance in the wells when the plate is opened at the first time. It will not have any effect on the final assay results. Do not remove microtiter plate from the storage bag until needed.
• Wrong operations during the reagents preparation and loading, as well as incorrect parameter setting for the plate reader may lead to incorrect results. A microplate plate reader with a bandwidth of 10nm or less and an optical density range of 0-3 O.D. or greater at 450 ± 10nm wavelength is acceptable for use in absorbance measurement. Please read the instruction carefully and adjust the instrument prior to the experiment.
• Even the same operator might get different results in two separate experiments. In order to get better reproducible results, the operation of every step in the assay should be controlled. Furthermore, a preliminary experiment before assay for each batch is recommended.
• Each kit has been strictly passed Q.C test. However, results from end users might be inconsistent with our in-house data due to some unexpected transportation conditions or different lab equipments. Intra-assay variance among kits from different batches might arise from above factors, too.
• Kits from different manufacturers for the same item might produce different results, since we have not compared our products with other manufacturers.

Kommentare:

Information on standard material:
The standard might be recombinant protein or natural protein, that will depend on the specific kit. Moreover, the expression system is E.coli or yeast or mammal cell. There is 0.05% proclin 300 in the standard as preservative.

Information on reagents:
The stop solution used in the kit is sulfuric acid with concentration of 1 mol/L. And the wash solution is TBS. The standard diluent contains 0.02 % sodium azide, assay diluent A and assay diluent B contain 0.01% sodium azide. Some kits can contain is BSA in them.

Information on antibodies:
The provided antibodies and their host vary in different kits.

Probenmenge: 100 μL

Testdauer: 3 h

Plattentyp: Pre-coated

Protokoll: 1. Prepare all reagents, samples and standards;
2. Add 100µL standard or sample to each well. Incubate 2 hours at 37°C;
3. Aspirate and add 100µL prepared Detection Reagent A. Incubate 1 hour at 37°C;
4. Aspirate and wash 3 times;
5. Add 100µL prepared Detection Reagent B. Incubate 30 minutes at 37°C;
6. Aspirate and wash 5 times;
7. Add 90µL Substrate Solution. Incubate 10-20 minutes at 37°C;
8. Add 50µL Stop Solution. Read at 450nm immediately.

Testpräzision:

Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level High Mobility Group Protein 1 (HMGB1) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level High Mobility Group Protein 1 (HMGB1) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Vorsichtsmaßnahmen: The Stop Solution suggested for use with this kit is an acid solution. Wear eye, hand, face, and clothing protection when using this material.

Handhabung: The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5 % within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.

Lagerung: 4 °C

Informationen zur Lagerung:

• For unopened kit: All the reagents should be kept according to the labels on vials. The Standard, Detection Reagent A, Detection Reagent B and the 96-well strip plate should be stored at -20°C upon receipt while the others should be at 4°C.
• For opened kit: When the kit is opened, the remaining reagents still need to be stored according to the above storage condition. Besides, please return the unused wells to the foil pouch containing the desiccant pack, and reseal along entire edge of zip-seal.
  Note: It is highly recommended to use the remaining reagents within 1 month provided this is within the expiration date of the kit.
• For ELISA kit, 1 day storage at 37°C can be considered as 2 months at 4°C, which means 3 days at 37°C equaling 6 months at 4°C.

Haltbarkeit: 6 months

Referenzen für HMGB1 ELISA Kit (ABIN414391)

Liu, Song, Zhang, Zhang, Gao, Su, Yang, Yin, Zheng, Ren, Yin, Pillai, Nath, Medina, Cosgrove, Bild, Badie: "RAGE Inhibitors as Alternatives to Dexamethasone for Managing Cerebral Edema Following Brain Tumor Surgery." in: Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics, (2022) (PubMed).

Zheng, Pan, Wei, Gao, Lin: "Dulaglutide mitigates inflammatory response in fibroblast-like synoviocytes." in: International immunopharmacology, Vol. 74, pp. 105649, (2020) (PubMed).

Wang, Zhao, Tong, Yang, Zhu, Li, Zhang: "BET bromodomain inhibitor JQ1 promotes immunogenic cell death in tongue squamous cell carcinoma." in: International immunopharmacology, Vol. 76, pp. 105921, (2020) (PubMed).

Huang, Guo, Wang, Wu, Li, Tian, Wang, Yan, Zhou, Yang: "HMGB1 Mediates Paraquat-Induced Neuroinflammatory Responses via Activating RAGE Signaling Pathway." in: Neurotoxicity research, Vol. 37, Issue 4, pp. 913-925, (2020) (PubMed).

Kostrzewa-Nowak, Ciechanowicz, Clark, Nowak: "Damage-Associated Molecular Patterns and Th-Cell-Related Cytokines Released after Progressive Effort." in: Journal of clinical medicine, Vol. 9, Issue 3, (2020) (PubMed).

Benlier, Solakhan, Yıldırım, Kaya, Yıldırım, Orhan, Çiçek, Yıldırım: "A novel diagnostic tool for the detection of bladder cancer: Measurement of urinary high mobility group box-1." in: Urologic oncology, Vol. 38, Issue 8, pp. 685.e11-685.e16, (2020) (PubMed).

Tomczyk, Kortas, Flis, Kaczorowska-Hac, Grzybkowska, Borkowska, Lewicka, Dabrowska-Kugacka, Antosiewicz: "Marathon Run-induced Changes in the Erythropoietin-Erythroferrone-Hepcidin Axis are Iron Dependent." in: International journal of environmental research and public health, Vol. 17, Issue 8, (2020) (PubMed).

Brajer-Luftmann, Nowicka, Kaczmarek, Wyrzykiewicz, Yasar, Piorunek, Grabicki, Kostrzewska, Sikora, Batura-Gabryel: "Molecules of Damage-Associated Patterns in Bronchoalveolar Lavage Fluid and Serum in Chronic Obstructive Pulmonary Disease." in: Advances in experimental medicine and biology, Vol. 1113, pp. 27-35, (2019) (PubMed).

Salaroglio, Panada, Moiso, Buondonno, Provero, Rubinstein, Kopecka, Riganti: "PERK induces resistance to cell death elicited by endoplasmic reticulum stress and chemotherapy." in: Molecular cancer, Vol. 16, Issue 1, pp. 91, (2018) (PubMed).

Lin, Biswas, Choolani, Fong, Bongso: "Induction of Immunogenic Cell Death in Lymphoma Cells by Wharton's Jelly Mesenchymal Stem Cell Conditioned Medium." in: Stem cell reviews, Vol. 13, Issue 6, pp. 801-816, (2018) (PubMed).

Wang, Peng, Huang, Liu, Kong, Dong, Dai, Zhou, Wang, Yang, Cheng, Gao, Qu, Wang, Zhu, Tian, Liu, Cao, Cui, Xu, Xu, Sun: "Blocking the Feedback Loop between Neuroendocrine Differentiation and Macrophages Improves the Therapeutic Effects of Enzalutamide (MDV3100) on Prostate Cancer." in: Clinical cancer research : an official journal of the American Association for Cancer Research, Vol. 24, Issue 3, pp. 708-723, (2018) (PubMed).

Oh, Park, Lee, Seo, Shin, Oh et al.: "Assessing the recovery from prerenal and renal acute kidney injury after treatment with single herbal medicine via activity of the biomarkers HMGB1, NGAL and KIM-1 in kidney proximal tubular cells ..." in: BMC complementary and alternative medicine, Vol. 17, Issue 1, pp. 544, (2018) (PubMed).

Riganti, Lingua, Salaroglio, Falcomatà, Righi, Morena, Picca, Oddo, Kopecka, Pradotto, Libener, Orecchia, Bironzo, Comunanza, Bussolino, Novello, Scagliotti, Di Nicolantonio, Taulli: "Bromodomain inhibition exerts its therapeutic potential in malignant pleural mesothelioma by promoting immunogenic cell death and changing the tumor immune-environment." in: Oncoimmunology, Vol. 7, Issue 3, pp. e1398874, (2018) (PubMed).

Li, Huang, Wang, Zhang: "Increased serum levels of high mobility group protein B1 and calprotectin in pre-eclampsia." in: International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, Vol. 142, Issue 1, pp. 37-41, (2018) (PubMed).

Rojas-Sepúlveda, Tittarelli, Gleisner, Ávalos, Pereda, Gallegos, González, López, Butte, Roa, Fluxá, Salazar-Onfray: "Tumor lysate-based vaccines: on the road to immunotherapy for gallbladder cancer." in: Cancer immunology, immunotherapy : CII, Vol. 67, Issue 12, pp. 1897-1910, (2018) (PubMed).

Keshk, Zineldeen, El-Heneedy, Ghali: "Thrombomodulin, alarmin signaling, and copeptin: cross-talk between obesity and acute ischemic stroke initiation and severity in Egyptians." in: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, Vol. 39, Issue 6, pp. 1093-1104, (2018) (PubMed).

Yan, Zhu, Zhang, Li, Li, Wang, Leng: "HMGB1-RAGE signaling pathway in pPROM." in: Taiwanese journal of obstetrics & gynecology, Vol. 57, Issue 2, pp. 211-216, (2018) (PubMed).

Chen, Fang, Li, Chen, Li, Gong, Fang: "Glycyrrhizin ameliorates experimental colitis through attenuating interleukin-17-producing T cell responses via regulating antigen-presenting cells." in: Immunologic research, Vol. 65, Issue 3, pp. 666-680, (2017) (PubMed).

Yin, Feng, Zhao, Zhao, Yua, Xu, Che: "SIRT1 inhibits releases of HMGB1 and HSP70 from human umbilical vein endothelial cells caused by IL-6 and the serum from a preeclampsia patient and protects the cells from death." in: Biomedicine & pharmacotherapy, Vol. 88, pp. 449-458, (2017) (PubMed).

Gmiat, Mieszkowski, Prusik, Prusik, Kortas, Kochanowicz, Radulska, Lipiński, Tomczyk, Jaworska, Antosiewicz, Ziemann: "Changes in pro-inflammatory markers and leucine concentrations in response to Nordic Walking training combined with vitamin D supplementation in elderly women." in: Biogerontology, Vol. 18, Issue 4, pp. 535-548, (2017) (PubMed).

Details zu HMGB1

Target: HMGB1 (High Mobility Group Box 1 (HMGB1))

Andere Bezeichnung: HMG1

Hintergrund: HMG1, HMG3, SBP1, Sulfoglucuronyl Carbohydrate Binding Protein, Amphoterin, High Mobility Group Box 1 Protein

UniProt: P09429

Pathways: p53 Signalweg, Regulation of Muscle Cell Differentiation, Skeletal Muscle Fiber Development, Positive Regulation of Endopeptidase Activity, Regulation of Carbohydrate Metabolic Process, Toll-Like Receptors Cascades, Smooth Muscle Cell Migration, Inflammasome